COLLABORATIVE ARRANGEMENTS (Details Textual) (USD $) In Thousands, unless otherwise specified	12 Months Ended
Dec. 31, 2014	Dec. 31, 2013
Research and Development Expense, Total	$ 2,678us-gaap_ResearchAndDevelopmentExpense	$ 1,712us-gaap_ResearchAndDevelopmentExpense
Sofgen Pharmaceuticals [Member] \| April 2014 Sofgen Agreement [Member]
Research and Development Expense, Total	100
Sofgen Pharmaceuticals [Member] \| August 2013 Sofgen Agreement [Member]
Research and Development Expense, Total	200	200
RiconPharma LLC [Member]
Research and Development Expense, Total	$ 400	$ 700

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details